Health Records Analysis Shows Gambling Diagnoses Climb in States With Legal Sports Betting

Researchers examined health records covering more than 197 million U.S. adults and documented a clear pattern tied to sports betting legalization, with problem gambling diagnoses climbing sharply in states that allow the activity while dropping in those that do not. The study tracked diagnosis rates before and after regulatory changes, revealing that states with legal sports betting saw diagnoses increase more than 60 percent to 4.8 per 100,000 people; states without legalization recorded a 29 percent decline to 2.2 per 100,000. These figures come from a large-scale review of electronic health data that compared trends across multiple jurisdictions over several years.

The analysis focused on clinical diagnoses rather than self-reported behavior, which allowed researchers to follow actual medical encounters. Observers note that the divergence between the two groups of states appeared consistently across different time periods and demographic slices. Data indicates the shift coincided with expanded access to mobile betting apps and retail sportsbooks in newly legalized markets, whereas non-legal states maintained existing restrictions on such platforms.

Study Scope and Methodology

Health systems contributed de-identified records spanning several years, giving analysts a broad view of how diagnosis codes for gambling disorder changed following policy shifts. The dataset included patients from both commercial insurers and public programs, which helped capture a representative cross-section of the adult population. Researchers applied standard diagnostic criteria to ensure consistency when counting cases across state lines.

States that legalized sports betting during the observation window formed the primary comparison group, while neighboring and distant states without such laws served as controls. This structure let the team isolate the effect of legalization from broader national trends in mental health reporting. Figures reveal that the overall sample size exceeded 197 million unique adults, providing statistical power to detect changes even in smaller age cohorts.

Age-Specific Trends Stand Out

The largest movement occurred among adults aged 18 to 29, where diagnosis rates doubled in legalized states. Younger adults in those jurisdictions showed the steepest slope on trend lines, while the same age group in non-legal states experienced either flat or declining rates. Analysts attribute part of the difference to higher smartphone penetration and greater engagement with sports media among this demographic, although the study itself measured only clinical outcomes rather than usage patterns.

Older age bands also registered increases in legalized states, yet the magnitude remained smaller than the jump seen in the youngest group. Data shows that middle-aged adults posted moderate rises, whereas rates among seniors stayed relatively stable. These age gradients help explain why overall state-level figures diverged so noticeably once sports betting became available through regulated channels.

State-by-State Comparisons Highlight Policy Impact

Legalized states posted uniform upward movement regardless of whether they adopted mobile-only models or permitted in-person betting as well. Non-legal states, by contrast, maintained lower baseline rates that continued to drift downward throughout the study period. The 60 percent rise and 29 percent drop represent average changes across the respective groups, with individual states clustering around those central figures.

Border effects received attention in the analysis, since residents of non-legal states sometimes travel to adjacent jurisdictions where betting is permitted. Even with potential cross-border activity, the aggregate data still showed lower diagnosis growth in states that kept sports betting illegal. Researchers adjusted for population mobility and insurance coverage differences to reduce confounding variables.

Nationwide Expansion Context in September 2026

As of September 2026, more than 30 states plus the District of Columbia have authorized some form of sports betting, and additional jurisdictions continue to debate legislation. The health records study arrives at a moment when several more states are preparing regulatory frameworks, which means the observed patterns could inform upcoming policy decisions. Public health officials have begun reviewing the findings alongside existing addiction treatment capacity in both legalized and non-legalized regions.

The study authors note that diagnosis rates remain low in absolute terms even after the increases, yet the relative change signals a measurable shift in clinical burden. Health systems in legalized states report greater demand for gambling-related counseling referrals, while providers in other states describe steady or reduced caseloads for the same condition.

Implications for Ongoing Monitoring

Because the analysis relied on existing medical records, it offers a replicable method for tracking future changes as sports betting spreads. States that legalize later can compare their post-legalization trajectories against the benchmark established by earlier adopters. Continued surveillance of diagnosis codes will help determine whether the pattern stabilizes, accelerates, or reverses with longer market maturity.

Insurance claims data and hospital discharge records already feed into similar monitoring systems for substance use disorders, so adding gambling disorder metrics requires minimal new infrastructure. The study demonstrates that such integration can surface policy-relevant signals within a relatively short time frame after regulatory changes take effect.

Conclusion

The health records review supplies concrete numbers linking sports betting legalization to rising clinical diagnoses of problem gambling, with the sharpest movement concentrated among younger adults. States without legalization recorded declines over the same interval, creating a clear contrast that future research can build upon. As additional jurisdictions consider regulatory changes in the months ahead, these findings provide one data point for evaluating potential public health effects.